FDA Inspection 1218571 — GXO Logistics Supply Chain Inc
The FDA completed an inspection of GXO Logistics Supply Chain Inc on September 18, 2023 in Dayton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 18, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dayton, NJ (United States)